Cytori Therapeutics said today it plans to acquire the liposomal nanoparticle technology platform of Azaya Therapeutics for up to $170 million, in a deal designed to expand and complement the buyer’s ...

Your Goa holidays have just gotten better. There’s a new ultra-luxe resort right on the pristine white sands of Benaulim beach with an unparalleled view of the Goa shoreline you must experience on ...

Cytori Therapeutics is set to gain cancer drugs and a liposomal nanoparticle technology platform through the acquisition of Azaya Therapeutics. The lead drug is a formulation of doxorubicin, the ...

Cytori Therapeutics Inc. stock surged 7.9% to $1.78 per share in morning trade Thursday after the company said it had agreed to purchase assets from privately-held Azaya Therapeutics. Under the terms ...

The deal comes about 14 months after the Alamo City company suspended operations. Azaya Therapeutics Inc., a San Antonio-based cancer drug developer, has agreed to sell its assets to Cytori ...

SAN ANTONIO--(BUSINESS WIRE)--Azaya Therapeutics Inc., a clinical-stage oncology company developing more effective cancer treatments through its nanotechnology platform, announced an exclusive license ...

> We all know that one of the most valuable resources in the clinical research industry is experienced staff. Yet it is commonly accepted that a clinical monitor will only stay with a company for ...

Azaya Therapeutics, Inc. announced that the Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for its lead product “ATI-1123,” a novel and improved ...